Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page
- Check5 days agoChange DetectedRecruitment status now indicates no participants are being recruited, which affects potential enrollees and the current relevance of the study page. New Help/Navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was standardized, and the page revision note was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check12 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, signaling a new software release for the page.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page's metadata tags were reduced by removing Melanoma and the related topics: MedlinePlus Genetics, altering the set of topics associated with the study.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedMelanoma was added as a topic/tag and 'related topics: MedlinePlus Genetics' was added, expanding the page's metadata and linking to genetic resources. The page's revision reference was updated from v3.5.3 to v3.5.4, reflecting a labeling/version update.SummaryDifference0.1%

- Check47 days agoChange DetectedMelanoma is added as a related topic. MedlinePlus Genetics is listed under related topics to provide cross-references to condition information.SummaryDifference0.1%

- Check54 days agoChange DetectedLocation entries just for Chile are updated to change how regional name text is displayed (e.g., removing the “Región de …” wording while keeping the same city/region information). The page revision/build identifier is also updated.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.